Greenwood, IN, United States of America

Michael Dean Minnett

This inventor holds 1 USPTO granted patent. Top assignee: Eli Lilly and Company. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Michael Dean Minnett. Retrieved from https://idiyas.com/inventor/michael-dean-minnett

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michael Dean Minnett: Innovator in Pharmaceutical Formulations

Introduction

Michael Dean Minnett is a notable inventor based in Greenwood, IN (US). He has made significant contributions to the field of pharmaceutical formulations, particularly with his innovative approach to stabilizing complex compounds.

Latest Patents

Minnett holds a patent for "Stabilized formulations of 6-hydroxy-3-(-4-[2-(piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl) benzo[b]thiophene and salts thereof." This invention focuses on pharmaceutical formulations that incorporate a stabilizing agent, such as methionine, acetylcysteine, or cysteine, to prevent oxidation and other forms of decomposition.

Career Highlights

He is currently associated with Eli Lilly and Company, where he continues to work on innovative solutions in the pharmaceutical industry. His expertise in stabilizing formulations has positioned him as a valuable asset in his field.

Collaborations

Minnett has collaborated with notable colleagues, including Fadia Najjar Bashore and Kerry John Hartauer, contributing to advancements in pharmaceutical research and development.

Conclusion

Michael Dean Minnett's work exemplifies the importance of innovation in the pharmaceutical sector. His patent for stabilized formulations showcases his commitment to improving drug stability and efficacy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…